Boston Scientific Corporation
corporate_fare Company Profile
Boston Scientific Corporation (NYSE:BSX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 35 items for BSX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-08, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for BSX spans 8-K, 10-Q.
Recent high-impact activity:
- Boston Scientific Says Cyberattack Will Cause It to Miss Guidance
- Cyberattack to Hit Q3 and Full-Year Results, Prompting Guidance Withdrawal
- Boston Scientific Targets Partial Shipment Restoration This Week After Cyberattack
- Cyberattack Halts Order Fulfillment at Boston Scientific, Shares Slide 4.2%
- Boston Scientific Hit by Cyberattack Disrupting Global Operations
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for BSX, detected from its recent SEC filings · based on capital-structure filings through 2026-04-01.
Definitive Merger Terms Filed · Merger Consideration Details
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Recent Capital Actions
-
2026-02-27 Proposed Mixed Merger +43.85M sh
-
2026-02-26 Executed Long-term debt ↓ −$3.27B (net of 7 line items)
-
2026-02-26 Executed Total debt ↓ −$3.27B (net of 7 line items)